Fc Receptors

Advances in Experimental Medicine and Biology

Volumn 640, Issue , 2008, Pages 22-34

  Powell, Maree S ^a,b   Hogarth, P Mark ^c  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 4; LEUKOTRIENE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; B LYMPHOCYTE ACTIVATION; CAPPING PHENOMENON; CELL SURFACE; CELLULAR DISTRIBUTION; CROSS LINKING; CYTOKINE RELEASE; CYTOTOXICITY; DEGRANULATION; ENDOCYTOSIS; GLOMERULONEPHRITIS; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOLOGY; KIDNEY FAILURE; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LIGAND BINDING; MACROPHAGE; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RESPIRATORY BURST; REVIEW; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; IMMUNOLOGY;

ANIMALS; HUMANS; IMMUNOGLOBULINS; RECEPTORS, FC;

EID: 58149356419     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09789-3_3     Document Type: Review

References (95)

1. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol 1994; 57:1-127.
2. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-234.
3. Ravetch JV, Boliand S. IgG Fc receptors. Annu Rev Immunol 2001; 19:275-290.
4. Kinet JR The high-affinity IgE receptor (Fc epsilon RI): From physiology to pathology. Annu Rev Immunol 1999; 17:931-972.
5. Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006; 68:103-114.
6. Gomes MM, Herr AB. IgA and IgA-specific receptors in human disease: Structural and functional insights into pathogenesis and therapeutic potential. Springer Semin Immunopathol 2006.
7. Reth M. Antigen receptor tail clue. Nature 1989; 338:383-384.
8. Daeron M, Latour S, Malbec O et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR- and FcR-dependent cell activation. Immunity 1995; 3:635-646.
9. Van den Herik-Oudijk IE, Ter Bekke MW, Tempelman MJ et al. Functional differences between two Fc receptor ITAM signaling motifs. Blood 1995; 86:3302-3307.
10. Metes D, Manciulea M, Pretrusca D et al. Ligand binding specificities and signal transduction pathways of Fc gamma receptor lie isoforms: the CD32 isoforms expressed by human NK cells. Eur J Immunol 1999; 29:2842-2852.
11. Lanier LL, Yu G, Phillips JH. Co-association of CD3 zeta with a receptor (CD 16) for IgG Fc on human natural killer cells. Nature 1989; 342:803-805.
12. Anderson P, Caligiuri M, O'Brien C et al. Fc gamma receptor type III (CD 16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 1990; 87:2274-2278.
13. Letourneur F, Klausner RD. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc Natl Acad Sci USA 1991; 88:8905-8909.
14. Kurosaki T, Gander I, Wirthmueller U et al. The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells. J Exp Med 1992; 175:447-451.
15. Isakov N. ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 1997; 16:85-100.
16. Muta T, Kurosaki T, Misulovin Z et al. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 1994; 369:340.
17. Brooks DG, Qiu WQ, Luster AD et al. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989; 170:1369-1385.
18. Van den Herik-Oudijk IE, Capel PJ, van der Bruggen T et al. Identification of signaling motifs within human Fc gamma Rlla and Fc gamma Rllb isoforms. Blood 1995; 85:2202-2211.
19. Pan LY, Mendel DB, Zurlo J et al. Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils and U-937 cells. J Immunol 1990; 145:267-275.
20. te Velde AA, Huijbens RJ, de Vries JE et al. IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes. J Immunol 1990; 144:3046-3051.
21. Welch GR, Wong HL, Wahl SM. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol 1990; 144:3444-3448.
22. Pricop L, Redecha P, Teillaud JL et al. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Thl and Th2 cytokines. J Immunol 2001; 166:531-537.
23. Tridandapani S, Wardrop R, Baran CP et al. TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J Immunol 2003; 170:4572-4577.
24. Gomez G, Ramirez CD, Rivera J et al. TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol 2005; 174:5987-5993.
25. Salmon JE, Pricop L. Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44:739-750.
26. Schmidt RE, Gessner JE. Fc receptors and their interaction with complement in autoimmunity. Immunol Lett 2005; 100:56-67.
27. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2:580-592.
28. Takai T. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 2005; 25:1-18.
29. McKenzie SE, Taylor SM, Malladi P et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: A transgenic mouse model. J Immunol 1999; 162:4311-4318.
30. Tan Sardjono C, Mottram PL, van dc Velde NC et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor Ila-transgenic mice. Arthritis Rheum 2005; 52:3220-3229.
31. On M, Billingsley JM, Jouvin MH et al. Molecular dissection of the FcRbeta signaling amplifier. J Biol Chem 2004; 279:45782-45790.
32. Pfefferkorn LC, Yeaman GR. Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J Immunol 1994; 153:3228-3236.
33. Morton HC, van den Herik-Oudijk IE, Vossebeld P et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/ FcR gamma chain association. J Biol Chem 1995; 270:29781-29787.
34. Wines BD, Trist HM, Ramsland PA et al. A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors FcalphaRI and FcepsilonRI. J Biol Chem 2006; 281:17108-17113.
35. Maruoka T, Nagata T, Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics 2004; 55:712-716.
36. Reljic R. In search of the elusive mouse macrophage Fc-alpha receptor. Immunol Lett 2006; 107: 80-81.
37. Wines BD, Hulett MD, Jamieson GP et al. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. J Immunol 1999; 162:2146-2153.
38. Wines BD, Sardjono CT, Trist HH et al. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 2001; 166:1781-1789.
39. Herr AB, Ballister ER, Bjorkman PJ. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgAl-Fc. Nature 2003; 423:614-620.
40. Pasquier B, Launay P, Kanamam Y et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: Dual role of FcRgamma ITAM. Immunity 2005; 22:31-42.
41. Hamerman JA, Lanier LL. Inhibition of immune responses by ITAM-bearing receptors. Sci STKE 2006; 2006:rel.
42. Maxwell KF, Powell MS, Hulett MD et al. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol 1999; 6:437-442.
43. Radaev S, Motyka S, Fridman WH et al. The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 2001; 276:16469-16477.
44. Sondermann P, Huber R, Oosthuizen V et al. The 3.2-A crystal structure of the human IgGl Fc fragment-Fc gammaRIII complex. Nature 2000; 406:267-273.
45. Woof JM, Burton DR. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol 2004; 4:89-99.
46. Garman SC, Wurzburg BA, Tarchevskaya SS et al. Structure of the Fc fragment of human IgE bound to its high-afiinity receptor Fc epsilonRI alpha. Nature 2000; 406:259-266.
47. Hulett MD, Hogarth PM. The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a. Mol Immunol 1998; 35:989-996.
48. Hulett MD, McKenzie IF, Hogarth PM. Chimeric Fc receptors identify immunoglobulin-binding regions in human Fc gamma RII and Fc epsilon RJ. Eur J Immunol 1993; 23:640-645.
49. Hulett MD, Witort E, Brinkworth RI et al. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J Biol Chem 1994; 269:15287-15293.
50. Hulett MD, Witort E, Brinkworth RI et al. Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG. J Biol Chem 1995; 270:21188-21194.
51. Kato K, Sautes-Fridman C, Yamada W et al. Structural basis of the interaction between IgG and Fcgamma receptors. J Mol Biol 2000; 295:213-224.
52. Dimcan AR, Woof JM, Partridge LJ et al. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 1988; 332:563-564.
53. Lund J, Winter G, Jones PT et al. Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. J Immunol 1991; 147:2657-2662.
54. Chappel MS, Isenman DE, Everett M et al. Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgGl/IgG2 hybrid and point-mutated antibodies. Proc Nad Acad Sci USA 1991; 88:9036-9040.
55. Ghirlando R, Keown MB, Mackay GA et al. Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgGl and its low-affinity receptor Fc gamma RIII. Biochemistry 1995; 34:13320-13327.
56. Keown MB, Ghirlando R, Mackay GA et al. Basis of the 1:1 stoichiometry of the high affinity receptor Fc epsilon RI-IgE complex. Eur Biophys J 1997; 25:471-476.
57. Powell MS, Barnes NC, Bradford TM et al. Alteration of the Fc gamma Rlla dimer interface aflFects receptor signaling but not ligand binding. J Immunol 2006; 176:7489-7494.
58. Pribluda VS, Pribluda C, Metzger H. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc Natl Acad Sci USA 1994; 91:11246-11250.
59. Barnes NC, Powell MS, Trist HM et al. Raft localisation of FcgammaRIIa and efficient signaling are dependent on palmitoylation of cysteine 208. Immunol Lett 2006; 104:118-123.
60. Katsumata O, Hara-Yokoyama M, Sautes-Fridman C et al. Association of FcgammaRII with low-density detergent-resistant membranes is important for cross-linking-dependent initiation of the tyrosine phosphorylation pathway and superoxide generation. J Immunol 2001; 167:5814-5823.
61. Kwiatkowska K, Frey J, Sobota A. Phosphorylation of FcgammaRIIA is required for the receptor-induced actin rearrangement and capping: the role of membrane rafts. J Cell Sci 2003; 116:537-550.
62. Wines BD, Trist HM, Monteiro RC et al. Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression and fiinction. J Biol Chem 2004; 279:26339-26345.
63. Floto RA, Clatworthy MR, Heilbronn KR et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; 11:1056-1058.
64. Kono H, Kyogoku C, Suzuki T et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B-cell receptor signaling. Hum Mol Genet 2005; 14:2881-2892.
65. Li X, Wu J, Carter RH et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003; 48:3242-3252.
66. Holowka D, Gosse JA, Hammond AT et al. Lipid segregation and IgE receptor signaling: A decade of progress. Biochim Biophys Acta 2005; 1746:252-259.
67. Kim MK, Huang ZY, Hwang PH et al. Fcgamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction and phagocytosis. Blood 2003; 101:4479-4484.
68. Lanier LL, Yu G, Phillips JH. Analysis of Fc gamma RIII (CD 16) membrane expression and association with CD3 zeta and Fc epsilon Rl-gamma by site-directed mutation. J Immunol 1991; 46:1571-1576.
69. Miller L, Alber G, Varin-Blank N et al. Transmembrane signaling in P815 mastocytoma cells by transfected IgE receptors. J Biol Chem 1990; 265:12444-12453.
70. Dombrowicz D, Flamand V, Miyajima I et al. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997; 99:915-925.
71. Dombrowicz D, Lin S, Flamand V et al. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 1998; 8:517-529.
72. Cosson P, Lankford SP, Bonifacino JS et al. Membrane protein association by potential intramembrane charge pairs. Nature 1991; 351:414-416.
73. Varin-Blank N, Metzger H. Surface expression of mutated subunits of the high affinity mast cell receptor for IgE. J Biol Chem 1990; 265:15685-15694.
74. Masuda M, Roos D. Association of all three types of Fc gamma R (CD64, CD32 and CD 16) with a gamma-chain homodimer in cultured human monocytes. J Immunol 1993; 151:7188-7195.
75. Remy I, Michnick SW. Clonal selection and in vivo quantitation of protein interactions with protein- fragment complementation assays. Proc Natl Acad Sci USA 1999; 96:5394-5399.
76. Zhang F, Yang B, Odin JA et al. Lateral mobility of Fc gamma Rlla is reduced by protein kinase C activation. FEBS Lett 1995; 376:77-80.
77. Larson DR, Gosse JA, Holowka DA et al. Temporally resolved interactions between antigen-stimulated IgE receptors and Lyn kinase on living cells. J Cell Biol 2005; 171:527-536.
78. Garrity D, Call ME, Feng J et al. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci USA 2005; 102:7641-7646.
79. Schamel WW, Reth M. Monomeric and oligomeric complexes of the B-cell antigen receptor. Immunity 2000; 13:5-14.
80. Call ME, Pyrdol J, Wiedmann M et al. The organizing principle in the formation of the T-cell receptor- CD3 complex. Cell 2002; 111:967-979.
81. Odin JA, Edberg JC, Painter CJ et al. Regulation of phagocytosis and [Ca2-l-]i flux by distinct regions of an Fc receptor. Science 1991; 254:1785-1788.
82. Indik Z, Kelly C, Chien P et al. Human Fc gamma RII, in the absence of other Fc gamma receptors, mediates a phagocytic signal. J Clin Invest 1991; 88:1766-1771.
83. Booth JW, Kim MK, Jankowski A et al. Contrasting requirements for ubiquitylation during Fc receptor- mediated endocytosis and phagocytosis. EMBO J 2002; 21:251-258.
84. Anderson CL, Shen L, Eicher DM et al. Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes. J Exp Med 1990; 171:1333-1345.
85. Bredius RG, Fijen CA, De Haas M et al. Role of neutrophil Fc gamma Rlla (CD32) and Fc gamma Rlllb (CD 16) polymorphic forms in phagocytosis of human IgGl- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994; 83:624-630.
86. Cox D, Greenberg S. Phagocytic signaling strategies: Fc(gamma)receptor- mediated phagocytosis as a model system. Semin Immunol 2001; 13:339-345.
87. Kim MK, Pan XQ, Huang ZY et al. Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis. Clin Immunol 2001; 98:125-132.
88. Indik ZK, Park JG, Hunter S et al. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood 1995; 86:4389-4399.
89. Edberg JC, Yee AM, Rakshit DS et al. The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex. J Biol Chem 1999; 274:30328-30333.
90. Beekman JM, Bakema JE, van de Winkel JG et al. Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity. Proc Natl Acad Sci USA 2004; 101:10392-10397.
91. Remvig L, Thomsen BS, Back L et al. Interleukin 1, but not interleukin 1 inhibitor, is released from human monocytes by immune complexes. Scand J Immunol 1990; 32:255-261.
92. Debets JM, Van de Winkel JG, Ceuppens JL et al. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Fimctional activation of Fc gamma RII by treatment with proteases or neuraminidase. J Immunol 1990; 144:1304-1310.
93. Feldmann M, Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 2005; 435:612-619.
94. Feldmann M, Brennan FM, Foxwell BM et al. Anti-TNF therapy: Where have we got to in 2005? J Autoimmim 2005; 25 Suppl:26-28.
95. Lerino FL, Powell MS, McKenzie IF et al. Recombinant soluble human Fc gamma RII: Production, characterization and inhibition of the Arthus reaction. J Exp Med 1993; 178:1617-1628.